Literature DB >> 36267134

MDMA and Their Analogs as Therapeutics for Mental Disorder and Response Predictor.

Robert B Kargbo1.   

Abstract

Provided herein are MDMA and their analogs for the potential psychotherapy-assisted treatment of alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), and a method of predicting dosing and patient response. Published 2022 by American Chemical Society.

Entities:  

Year:  2022        PMID： 36267134      PMCID： PMC9578019          DOI： 10.1021/acsmedchemlett.2c00389

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


  6 in total

Review 1.  MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.

Authors:  Kimberly W Smith; Dakota J Sicignano; Adrian V Hernandez; C Michael White
Journal:  J Clin Pharmacol       Date:  2021-11-28       Impact factor: 3.126

Review 2.  Review of potential psychedelic treatments for PTSD.

Authors:  Ryan L Henner; Matcheri S Keshavan; Kevin P Hill
Journal:  J Neurol Sci       Date:  2022-05-30       Impact factor: 4.553

Review 3.  Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.

Authors:  Aryan Sarparast; Kelan Thomas; Benjamin Malcolm; Christopher S Stauffer
Journal:  Psychopharmacology (Berl)       Date:  2022-03-07       Impact factor: 4.415

Review 4.  Challenges in translational research: MDMA in the laboratory versus therapeutic settings.

Authors:  Harriet de Wit; Anya K Bershad; Charles Grob
Journal:  J Psychopharmacol       Date:  2021-05-04       Impact factor: 4.153

Review 5.  MDMA and memory, addiction, and depression: dose-effect analysis.

Authors:  Madeline M Pantoni; Jinah L Kim; Kaitlin R Van Alstyne; Stephan G Anagnostaras
Journal:  Psychopharmacology (Berl)       Date:  2022-02-18       Impact factor: 4.415

Review 6.  Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.

Authors:  David E Nichols
Journal:  Front Psychiatry       Date:  2022-03-25       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.